foxo4 dri sequence FOXO4-DRI | FOXO4/p53 Interaction Blocker FOXO4-DRI Vial 10mg — Stemcode
FOXO4 DRI Vial 10mg Stemcode Peptides FOX04 DRI Apollo Peptide Sciences FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Pay in 4 interest-free payments of $5.33 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13



